Resultados de la búsqueda 51-60 of 5363 for ⏳구글 백링크 프로그램 [ ADSFIX.NET 텔 ADSFIX01 ] 구글 웹문서배포 업체 구글 웹문서찌라시 광고 구글 웹문서찌라시 홍보 구글1페이지대행업체 구글1페이지전문⏳
Patients will be randomized in a 1:1 ratio to ... Android App on Google Play · Apple Download on the App ... web. Por favor, visite nuestra Política de ...
1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Rochester, Minn. The aim of this study is to examine the role of mast cell mediators in children with allergic disorders in a two part study. Part 1 of ...
Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...
... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...
... 1 focuses on cancers displaying a high (80-90 ... Android App on Google Play · Apple Download on the App ... web. Por favor, visite nuestra Política de ...
A Phase 1, Study of BMF-500 in Adults With Acute Leukemia. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to ...
Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?